Read more about the new restrictions on phenylene bis-diphenyltriazine, 2-chloro-p-phenylenediamine and climbazole in cosmetics products on the European market.

Read more about the new restrictions on phenylene bis-diphenyltriazine, 2-chloro-p-phenylenediamine and climbazole in cosmetics products on the European market.
EU announce first corrigenda to medical and in-vitro device regulations. Some make formal changes while others amended content. Learn more with Obelis.
The Safety Assessment procedure is an important part of the cosmetics compliance process. Find out if this can be done in a lab outside the EU.
Danish authorities ask for clarification on processes for 'free from' claims for cosmetics products on the European market.
What does the new standard on Medical Device Regulation say.
There are many things to consider when introducing a product to the European Market for the first time. Right at the top of that list is: What is the background of my third-party producer and are there any barriers to their components entering the market?
European Cosmetics Regulation 2019/831 has been published. In effect, it amends Annexes II, III, and V of Regulation 1223/2009/EC.
With 12 months to go until European Medical Device Regulation 2017/745 comes into effect in May 2020, we look at how to prepare your products for compliance.
What are the duties of the Responsible Person, after the CPNP registration process and how do they influence the importance of the manufacturer's role?
Though both are involved in the EU Compliance process and CE Marking, a European Authorized Representative and a Notified Body are not mutually exclusive bodies. Both have roles unique to themselves throughout the EU Compliance procedure. In order to clear up a few common misconceptions regarding European Authorized Representatives (EAR) and Notified Bodies (NB), this blog will outline the definitions and roles of each.